Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 955-962

  Al Ahmad, Amin ^a   Rand, William M ^a   Manjunath, Guruprasad ^a   Konstam, Marvin A ^a   Salem, Deeb N ^a   Levey, Andrew S ^a   Sarnak, Mark J ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CALCULATION; CAUSE OF DEATH; DATA BASE; DISEASE ASSOCIATION; EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FAILURE; HEMATOCRIT; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME;

DOUBLE-BLIND METHOD; GLOMERULAR FILTRATION RATE; HEMATOCRIT; HUMANS; KIDNEY; MULTICENTER STUDIES; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034812030     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01470-X     Document Type: Article

References (31)

1. The erythrocyte sedimentation rate in congestive heart failure
2. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
3. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormone profiles
4. Renal function, neurohormonal activation, and survival in patients with chronic heart failure
5. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
6. Iatrogenic congestive heart failure in older adults: Clinical course and prognosis
7. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
8. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
9. Studies Of Left Ventricular Dysfunction (SOLVD) - Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
10. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
11. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
12. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease study group
13. A simplified equation to predict glomerular filtration rate from serum creatinine
14. Epidemiology of heart failure in the United States
15. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of Veterans Administration Cooperative study
16. The effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
17. The effect of spirinolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation study investigators
18. Effect of oral milrinone on mortality in severe chronic heart failure
19. Comparison of one-year outcome in women versus men with chronic congestive heart failure
20. Measurement of renal function in chronic renal disease
21. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery
22. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
23. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) phenotypes predict coronary artery disease in hemodialysis patients
24. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology and potential relationship to arteriosclerotic outcomes
25. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
26. Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease
27. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients
28. Morbidity risk assessment in the surgically anemic patient
29. Pathophysiology of anaemia: Focus on the heart and blood vessels
30. Effects of anaemia on cardiovascular status